🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our work on “Identification of Pancreatic Cancer Germline Risk Variants With Effects That Are Modified by Smoking”, published today in JCO Precision Oncology JCO Precision Oncology ascopubs.org/doi/10.1200/PO…

Congratulations David Ting Eunae You on their latest work in Cell, showing how repeat RNA elements in extracellular vesicles create a viral-like infection in the pancreatic cancer microenvironment. cell.com/cell/fulltext/…

Now online! Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer dlvr.it/TFC6JY

Our CSO Heike Keilhack is speaking on the “Innovation without Borders: How the Immigrant Mindset has Helped Power the Biotech Industry in the U.S.” panel on the intersection of immigration, innovation, and biotechnology. Register here: labcentral.swoogo.com/innovationwith… LabCentral

💇‍♂️ I might be biased, but I’m pretty sure I have the best hair in the game. 💁‍♂️✨ #HairGoals #Flawless

Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer: Cell cell.com/cell/fulltext/…

We are hiring a Software Engineer for the new Olayan Center for Cancer Vaccines Memorial Sloan Kettering Cancer Center. We hope you will consider joining our new endeavor with Vinod BalachandranMD! Experience in development for varied users, Comp Bio & AI/ML is a plus 👇👇👇 externaltalent-mskcc.icims.com/jobs/81953/bio…

The cancer risk of repeat RNAs | Science Signaling science.org/doi/10.1126/sc…

In the latest issue! Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy dlvr.it/TGC0dP

Quite surprised to receive this and honored to have been nominated by my colleagues - together we are trying to change how we do collaborative research and ultimately, how we treat #AML. David Livingston was a legend here Dana-Farber and in the cancer research community.

In the latest issue! Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissues dlvr.it/TGCzLH

And I should add that we are affiliated with the Dana-Farber soon

⭐️NEW PAPER OUT in nature⭐️ 🫀What is the relationship between the immune responses in the heart, blood, and tumor in patients with inflammation in the heart resulting from cancer immunotherapy (irMyocarditis)? This 🧵 breaks down the key findings 1/n nature.com/articles/s4158…

Up next at #DGS2024 is a panel discussion entitled “Beyond Coding: Unraveling the Regulation and Unconventional Functions of the #DarkGenome” featuring panelists from both industry and academia.

We’re proud to debut the first preclinical data of ROME’s LINE-1 RT inhibitors in #NeurodegenerativeDiseases at #DGS2024. These data in #ParkinsonsDisease will be presented at a short talk podium presentation later this morning. Learn more: rometx.com/press-releases… #DarkGenome

Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms cell.com/immunity/fullt… @immunitycp Benjamin D. Greenbaum Siyu Sun

The next #DGS2024 panel will discuss the question: “Is the #DarkGenome an instigator or innocent bystander in autoimmunity and neurodegeneration?” Looking forward to further illumination of this next frontier in biology and its potential role in challenging diseases.

Really exciting work in illuminating the Dark Genome in pancreatic cancer immunity. Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms: Immunity cell.com/immunity/fullt…

The final #DarkGenomeSymposium panel discussion will discuss: “Are Dark Antigens the Key to Off-The-Shelf Approaches for Next-Generation Immuno-Oncology Targets?” #DGS2024

LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma aacrjournals.org/cancerdiscover…